Substituting HCG with GnRH agonist to trigger final follicular maturation–a retrospective comparison of three different ovarian stimulation protocols
R Orvieto, J Rabinson, S Meltzer, E Zohav… - Reproductive …, 2006 - Elsevier
The study retrospectively evaluated the influence of triggering final oocyte maturation with
gonadotrophin-releasing hormone (GnRH) agonist on the outcome of IVF cycles. Four …
gonadotrophin-releasing hormone (GnRH) agonist on the outcome of IVF cycles. Four …
[HTML][HTML] Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist for patients with repeated IVF failures and poor embryo quality
To evaluate the appropriate controlled ovarian hyperstimulation (COH) protocol in patients
with repeated IVF failures and poor embryo quality we compared the stimulation …
with repeated IVF failures and poor embryo quality we compared the stimulation …
Different gonadotropin releasing hormone agonist doses for the final oocyte maturation in high-responder patients undergoing in vitro fertilization/intra-cytoplasmic …
EG Pabuccu, R Pabuccu, GS Caglar… - Journal of Human …, 2015 - journals.lww.com
AIMS: The aim of the current study is to compare the impact of different GnRH-a doses for
the final oocyte maturation on cycle outcomes and ovarian hyperstimulation syndrome …
the final oocyte maturation on cycle outcomes and ovarian hyperstimulation syndrome …
[HTML][HTML] Comparisons of the effects of long-acting and short-acting GnRH agonists on embryo quality, endometrial thickness and pregnancy rate in human in vitro …
GH Mao, Z Feng, Y He, YR Huang - Archives of Medical Science …, 2014 - ncbi.nlm.nih.gov
Results There were no significant differences between the long and short-acting GnRH
group (63.16% vs. 66.26%, p> 0.05), and the secondary and primary infertility group …
group (63.16% vs. 66.26%, p> 0.05), and the secondary and primary infertility group …
[HTML][HTML] Ovarian stimulation in in vitro fertilization with or without the “long” gonadotropin-releasing hormone agonist protocol: effect on cycle duration and outcome
R Beloosesky, S Kol, A Lightman, J Itskovitz-Eldor - Fertility and sterility, 2000 - Elsevier
Objective: To study the correlation between stimulation duration of IVF cycles, with and
without GnRH agonist (GnRH-a), and cycle outcome. Design: Retrospective analysis of data …
without GnRH agonist (GnRH-a), and cycle outcome. Design: Retrospective analysis of data …
MILD ovarian stimulation with GnRH-antagonist vs. long protocol with low dose FSH for non-PCO high responders undergoing IVF: a prospective, randomized study …
S Casano, D Guidetti, A Patriarca, G Pittatore… - Journal of Assisted …, 2012 - Springer
Objective To compare the effectiveness of two stimulation protocols in non-polycystic ovary
(PCO) high responders undergoing in vitro fertilization (IVF). Design Prospective …
(PCO) high responders undergoing in vitro fertilization (IVF). Design Prospective …
Antagonist rescue of agonist IVF cycle at risk of OHSS: a case series
F Martínez, F Mancini, M Solé… - Gynecological …, 2014 - Taylor & Francis
We describe a series of in vitro fertilisation (IVF) long protocol cycles presenting a risk of
ovarian hyperstimulation syndrome (OHSS) which were rescued with an antagonist at a …
ovarian hyperstimulation syndrome (OHSS) which were rescued with an antagonist at a …
[HTML][HTML] Estradiol supplementation during the luteal phase may improve the pregnancy rate in patients undergoing in vitro fertilization-embryo transfer cycles
J Farhi, A Weissman, Z Steinfeld, M Shorer, H Nahum… - Fertility and sterility, 2000 - Elsevier
Objective: To evaluate the effect of adding E2 to progestin supplementation during the luteal
phase on pregnancy and implantation rates in patients undergoing IVF cycles. Design …
phase on pregnancy and implantation rates in patients undergoing IVF cycles. Design …
Efficacy and safety of long-acting GnRH agonists in in vitro fertilization and embryo transfer
SF Marcus, WL Ledger - Human Fertility, 2001 - Taylor & Francis
The introduction of gonadotrophin-releasing hormone (GnRH) agonists combined with
gonadotrophins is considered to be one of the most significant events in the development of …
gonadotrophins is considered to be one of the most significant events in the development of …
[HTML][HTML] Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated …
EM Kolibianakis, C Albano, J Kahn, M Camus… - Fertility and sterility, 2003 - Elsevier
OBJECTIVE: To compare ongoing implantation rates under two different GnRH antagonist
protocols. DESIGN: Randomized controlled trial. SETTING: Tertiary referral center. PATIENT …
protocols. DESIGN: Randomized controlled trial. SETTING: Tertiary referral center. PATIENT …